Ontology highlight
ABSTRACT:
SUBMITTER: Brockway M
PROVIDER: S-EPMC6510380 | biostudies-literature | 2019 May
REPOSITORIES: biostudies-literature
Brockway Marina M Mason Jay W JW Brockway Brian P BP
Clinical and translational science 20190128 3
Since introduction of the International Conference on Harmonization proarrhythmia guidelines in 2005, no new marketed drugs have been associated with unacceptable risk of Torsade de Pointes. Although cardiac safety improved, these guidelines had the unintended consequence of eliminating potentially beneficial drugs from pipelines early in development. More recently, it has been shown that a corrected QT (QTc) prolonging drug may be safe if it impacts multiple ion channels vs. only human ether-a- ...[more]